NCT03713567

Brief Summary

The objective of this study is to evaluate, through clinical, microbiological and immunological tests, the changes during the experimental gingivitis and mucositis model, between teeth and implants, and between patients with a history of aggressive periodontitis and healthy individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 7, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 9, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

October 19, 2018

Completed
Last Updated

October 19, 2018

Status Verified

October 1, 2018

Enrollment Period

4 months

First QC Date

October 9, 2018

Last Update Submit

October 17, 2018

Conditions

Keywords

Aggressive PeriodontitisBiomarkersMicrobiotaDental Implants

Outcome Measures

Primary Outcomes (1)

  • Changes of Modified Gingival Index in five different periods

    According to the method of Löe \& Silness (1963) without the bleeding in the component of prueba.Measure at each visit 0 - absence of inflammation; 1. \- Light inflammation - slight color change and little alteration in gingival texture; 2. \- Moderate inflammation - moderate texture change, redness, edema, hypertrophy. 3. \- Severe inflammation - redness, hypertrophy.

    Baseline, 7 days, 14 days, 21 days, 42 days

Secondary Outcomes (2)

  • Changes of Angulated Bleeding Index in five different periods

    Baseline, 7 days, 14 days, 21 days, 42 days

  • Changes of Plaque Index in five different periods

    Baseline, 7 days, 14 days, 21 days, 42 days

Other Outcomes (1)

  • Changes of Gingival fluid in five different periods

    Baseline, 7 days, 14 days, 21 days, 42 days

Study Arms (2)

Experimentally induced plaque

PLACEBO COMPARATOR

Induced inflammation by suspension of oral hygiene

Behavioral: Experimentally induced plaque

Experimentally induced plaque GAP

EXPERIMENTAL

Induced inflammation by suspension of oral hygiene in patients with history of Generalized Aggressive periodontitis

Behavioral: Experimentally induced plaque

Interventions

Experimentally induced plaque by suspension of oral hygiene only in the tested areas (tooth / implant), protected by a personalized stent made of plastic, according to the experimental gingivitis and mucositis model of 21 days of duration

Experimentally induced plaqueExperimentally induced plaque GAP

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged ≥ 18 years,
  • History of aggressive periodontitis diagnosed according to the Armitage classification (1999) and verified by the dental chart and time of radiographic bone emission, being in periodontal maintenance for a little more than 6 months (Test group).
  • Presence of teeth and implants (unitary prostheses) in the mouth; in a similar and counter-lateral position in the arch. The implants are the same system, including protective and dimensions.
  • Probing Depth \<5mm, in the interest sites.
  • Plaque Index ≤ 20% (Silness \& Löe, 1964),
  • Healthy patients
  • Signature of free and informed consent.

You may not qualify if:

  • Probing Depth\> 5mm, in the interest sites.
  • History of bone loss by peri-implantitis in the implant test.
  • Smoking;
  • Pregnancy;
  • Presence of systemic disorders (diabetes, hypertension, heart disease or any other condition that could contraindicate periodontal surgery);
  • Use of medications (immunosuppressants, phenytoin or anything else that might affect mucosal healing and repair);

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Piracicaba Dental School, State University of Campinas

Piracicaba, São Paulo, 13414-903, Brazil

Location

Related Publications (1)

  • Dutra TP, Freitas Monteiro M, Franca-Grohmann IL, Casarin RCV, Casati MZ, Silverio Ruiz KG, Kumar PS, Sallum EA. Clinical, immunological and microbiological evaluation of experimental peri-implant mucositis and gingivitis in subjects with Grade C, stage III/IV periodontitis background. J Clin Periodontol. 2024 Feb;51(2):209-221. doi: 10.1111/jcpe.13896. Epub 2023 Nov 8.

MeSH Terms

Conditions

GingivitisMucositisAggressive Periodontitis

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesPeriodontitis

Study Officials

  • Tamires P Dutra, G

    School of Odontology of Piracicaba - Unicamp

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

October 9, 2018

First Posted

October 19, 2018

Study Start

November 7, 2017

Primary Completion

March 20, 2018

Study Completion

June 6, 2018

Last Updated

October 19, 2018

Record last verified: 2018-10

Locations